CLINICAL_TRIALS
trial_result
· 2020-03-27
Clinical Trial Update: Efficacy and Safety of HCP1102 Capsule in Patients With Perennial Allergic Rhinitis [Phase 3]
Summary
Phase 3 trial update on HCP1102 capsule evaluating efficacy and safety in perennial allergic rhinitis.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hanmi Pharmaceutical Company Limited | Conditions: Perennial Allergic Rhinitis | Phase 3 | Status: COMPLETED